Financial Projections - The estimated net profit for 2025 is projected to be between 3,700,000 and 5,550,000 CNY, representing a decrease of 68.62% to 79.08% compared to the previous year's profit of 17,685,680 CNY[5] - The net profit after deducting non-recurring gains and losses is expected to be between 3,900,000 and 5,850,000 CNY, showing an increase of 135.63% to 153.44% from a loss of 10,946,170 CNY in the same period last year[5] - The basic earnings per share is projected to be between 0.048 and 0.072 CNY, down from 0.23 CNY per share in the previous year[5] - The financial data in the earnings forecast is preliminary and subject to final audit results in the 2025 annual report[9] Company Strategy and Operations - The company's asset-liability ratio has improved significantly, now below 20%, due to better financial conditions and reduced interest expenses and exchange losses[8] - The company plans to accelerate the layout of downstream emerging application fields and focus on high-tech, high-value-added businesses as part of its "14th Five-Year Plan" strategy[8] - Continuous efforts will be made to enhance management and production efficiency, aiming for cost reduction and quality upgrades[8] - The company emphasizes a long-term approach to achieve stable operations and optimize business performance amid industry cycle fluctuations[8]

证券代码：002024 证券简称：ST 易购 公告编号：2026-011 苏宁易购集团股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况： 单位：万元 | 项目 | 本报告期 | | | 上年同期 | | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | 比上年同期 | ～ 5,000.00 | 7,500.00 | 61,061.1 | | | 下降 | ～ 91.81% | 87.72% | | | 归属于上市公司股东的扣除非经常性损 益后的净利润 | -465,000.00 | ～ | -412,500.00 | -102,497.8 | | 基本每股收益（元/股） | | ～ 0.005 | 0.008 | 0.07 | 本次业绩预告相关数据是公司财务部门初步测算的结果，未经会计师事务所审计。公 司已就业绩预告有关事项与年报审计会计师事务所进行了预沟 ...

二、与会计师事务所沟通情况 证券代码：002183 证券简称：怡亚通 公告编号：2026-015 深圳市怡亚通供应链股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 （1）以区间数进行业绩预告的 单位：万元 | 项 目 | 本报告期 | | | | | 上年同期 | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司 | -30,000 比上年同期 | | | ～ | -20,000 | 10,585.88 | | 股东的净利润 | | | 383.40% | ～ | 288.93% | | | | 下降 | | | | | | | 扣除非经常性损 | | -39,000 | | ～ | -26,000 | | | 益后的净利润 | 比上年同期 | | 524.07% | ～ | 382.72% | 9,196.54 | | | 下降 | | | | | | | 基本每股收益 | | -0.12 | | ～ | -0.08 | 0.04 | | （ ...

Financial Performance Expectations - The company expects a net profit attributable to shareholders of between 8 million and 12 million yuan for 2025, marking a turnaround from a loss of 21.2952 million yuan in the previous year[4] - The net profit after deducting non-recurring gains and losses is projected to be a loss of between 8 million and 12 million yuan, compared to a loss of 46.6506 million yuan last year[4] - Basic earnings per share are expected to be between 0.0112 yuan and 0.0168 yuan, recovering from a loss of 0.0299 yuan per share in the previous year[4] Factors Contributing to Improvement - The improvement in net profit is attributed to cost reduction and efficiency enhancement, leading to lower operating expenses[6] - The company has strengthened accounts receivable management, resulting in a decrease in credit impairment losses compared to the previous year[6] - Investment income for 2025 is expected to increase compared to the previous year, contributing positively to the overall profit[6] Earnings Forecast and Risks - The financial data in the earnings forecast has not been audited and may differ from the final figures in the 2025 annual report[5] - There are no significant uncertainties affecting the accuracy of this earnings forecast[7] - The company advises investors to make cautious decisions and be aware of investment risks[7] - The earnings forecast period is from January 1, 2025, to December 31, 2025[3]

Financial Performance - The company expects a net loss attributable to shareholders of approximately 132 million RMB for 2025, compared to a loss of 44.36 million RMB in the same period last year[3]. - The net profit after deducting non-recurring gains and losses is projected to be a loss of 130 million RMB, compared to a loss of 43.27 million RMB in the previous year[3]. - The basic earnings per share is expected to be -1.22 RMB, down from -0.41 RMB per share in the same period last year[3]. Reasons for Performance Decline - The primary reason for the performance decline is the rising cost of whey protein and increasing competitive pressure in the sports nutrition sector[5]. Impairment and Future Plans - The company anticipates an impairment loss on intangible assets between 950 million to 1.5 billion RMB, subject to final audit[5]. - In 2026, the company plans to diversify its product portfolio and reduce reliance on whey protein, focusing on high-margin products in new protein, creatine, peptides, and collagen[6]. Investment and Operational Strategy - The company will increase investment in digital channels, with Amazon as a core growth engine, and optimize product offerings at Walmart[6]. - A dynamic budget monitoring mechanism will be established to control expenses and improve operational efficiency[6]. Audit and Investment Risks - The preliminary financial data has not been audited by an accounting firm and is subject to change[7]. - Investors are advised to pay attention to investment risks as the data is based on initial estimates and will be detailed in the 2025 annual report[7].

证券代码：300209 证券简称：有棵树 公告编号：2026-011 有棵树科技股份有限公司 2025年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 二、与会计师事务所沟通情况 公司已就业绩预告有关事项与年报审计会计师事务所进行了预沟通，公司与 会计师事务所在本报告期的业绩预告方面不存在重大分歧。 三、业绩变动原因 本报告期内，公司营业收入较上年度有所下降，整体经营利润处于亏损状态。 主要变动原因如下： 有棵树科技股份有限公司（以下简称"公司"）2025 年度业绩预告是公司 财务部门初步测算的结果，未经会计师事务所审计。具体情况公告如下： 一、本期业绩预计情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日 （二）业绩预告情况 预计净利润为负值 | 项目 | 本报告期 | 上年同期 | | --- | --- | --- | | 归属于上市公司股 | 亏损：7,000 万元-9,000 万元 | 盈利：5,675.97 万元 | | 东的净利润 | | | | 扣除非经常性损益 | 亏损：8,000 万元-1 ...

Financial Performance - The company expects a net profit in the range of -19,000 to -15,000 thousand CNY for the fiscal year 2025, representing a decrease of 21.33% to 37.89% compared to the previous year[5]. - The expected operating revenue for 2025 is projected to be between 85,000 and 87,000 thousand CNY, an increase from 68,167.55 thousand CNY in the previous year[5]. - Non-recurring gains and losses are expected to impact net profit by approximately 2,294.60 thousand CNY during the reporting period[10]. - The financial data for the full year 2025 will be disclosed in detail in the annual report[11]. Investment and Growth Strategy - The company plans to increase R&D investment, accelerate new product launches, and optimize product structure to drive sales volume and revenue growth compared to 2024[7]. - The company has recorded a share-based payment expense of 2,856.89 thousand CNY for 2025[9]. Inventory and Impairment - The company has recognized an inventory impairment loss of approximately 6,745.13 thousand CNY during the reporting period[8]. Communication and Transparency - The company has communicated with the auditing firm regarding the preliminary financial data, and there are no significant disagreements[6]. - The company emphasizes the importance of rational investment and risk awareness for investors[11]. - The announcement of the earnings forecast was made on January 30, 2026[13].

| 证券代码：600745 | 证券简称：闻泰科技 | 公告编号：临 | 2026-009 | | --- | --- | --- | --- | | 转债代码：110081 | 转债简称：闻泰转债 | | | 闻泰科技股份有限公司 2025年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 经财务部门初步测算，预计 2025 年度实现归属于母公司所有者的净利润 -1,350,000 万元到-900,000 万元，将出现亏损。 预计 2025 年年度实现归属于母公司所有者的扣除非经常性损益后的净利润 -30,000 万元到-20,000 万元。 （三）本次业绩预告的相关财务数据未经注册会计师审计。 二、上年同期经营业绩和财务状况 业绩预告的具体适用情形：净利润为负值。 闻泰科技股份有限公司（以下简称"公司"）预计 2025 年度实现归属 于母公司所有者的净利润-1,350 ...

Financial Performance Expectations - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -160 million and -200 million yuan, indicating an increase in losses compared to the previous year by 169 million to 209 million yuan [2][4]. - The projected net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is expected to be between -240 million and -310 million yuan [2][4]. - In the previous year, the total profit was 11.269 million yuan, with a net profit attributable to shareholders of the parent company of 8.5831 million yuan, and a net profit of -35.715 million yuan after deducting non-recurring gains and losses [5]. - The company reported a basic earnings per share of 0.01 yuan in the previous year [6]. Reasons for Expected Loss - The main reasons for the expected loss include significant downward pressure in the domestic construction industry due to a weak macroeconomic environment and intensified market competition, leading to reduced operating income and further decline in project gross margins [7]. - The company has proactively reduced its market scope and focused on the local market, resulting in a decrease in construction volume [7]. - There has been an increase in the impairment provision for receivables, leading to higher impairment losses on receivables during the reporting period [8]. Forecast Accuracy and Data - As of the announcement date, there are no significant uncertainties affecting the accuracy of this earnings forecast [9]. - The forecast data is preliminary and subject to final audited financial data to be disclosed in the 2025 annual report [10].

皓宸医疗科技股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、本期业绩预计情况 证券代码：002622 证券简称：皓宸医疗 公告编号：2026-002 （一）业绩预告期间：2025 年 1 月 1 日——2025 年 12 月 31 日 （二）业绩预告情况：预计净利润为负值 | 项 目 | | 本报告期 | | 上年同期 | | | --- | --- | --- | --- | --- | --- | | 营业收入 | 65,000 | 万元-75,000 万元 | | 86,156.84 | 万元 | | 归属于上市公司 股东的净利润 | 亏损：14,000.00 | 万元-7,000.00 | 万元 | 亏损：3,769.09 | 万元 | | 扣除非经常性损 益后的净利润 | 亏损：13,000.00 | 万元–6,500.00 | 万元 | 亏损：2,388.33 | 万元 | | 基本每股收益 | 亏损：0.1666 | 元/股–0.0833 | 元/股 | 亏损：0.0449 | 元/股 | 二、与会计师事 ...